Iwamoto, H.; Niizeki, T.; Nagamatsu, H.; Ueshima, K.; Nomura, T.; Kuzuya, T.; Kasai, K.; Kooka, Y.; Hiraoka, A.; Sugimoto, R.;
et al. Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular Carcinoma. Cancers 2021, 13, 646.
https://doi.org/10.3390/cancers13040646
AMA Style
Iwamoto H, Niizeki T, Nagamatsu H, Ueshima K, Nomura T, Kuzuya T, Kasai K, Kooka Y, Hiraoka A, Sugimoto R,
et al. Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular Carcinoma. Cancers. 2021; 13(4):646.
https://doi.org/10.3390/cancers13040646
Chicago/Turabian Style
Iwamoto, Hideki, Takashi Niizeki, Hiroaki Nagamatsu, Kazuomi Ueshima, Takako Nomura, Teiji Kuzuya, Kazuhiro Kasai, Yohei Kooka, Atsushi Hiraoka, Rie Sugimoto,
and et al. 2021. "Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular Carcinoma" Cancers 13, no. 4: 646.
https://doi.org/10.3390/cancers13040646
APA Style
Iwamoto, H., Niizeki, T., Nagamatsu, H., Ueshima, K., Nomura, T., Kuzuya, T., Kasai, K., Kooka, Y., Hiraoka, A., Sugimoto, R., Yonezawa, T., Ishihara, A., Deguchi, A., Arai, H., Shimose, S., Shirono, T., Nakano, M., Okamura, S., Noda, Y.,
... Kurume Liver Cancer Study Group of Japan.
(2021). Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular Carcinoma. Cancers, 13(4), 646.
https://doi.org/10.3390/cancers13040646